|
Market Closed -
Hong Kong S.E.
03:08:15 2026-11-02 EST
|
5-day change | 1st Jan Change | ||
| 0.4300 HKD | -1.15% |
|
-6.52% | -14.00% |
| 08-28 | Mabpharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-24 | Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection) | CI |
Stock exchange
Hong Kong S.E.
2181 0.4300 $
-1.15%
9.46K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| 2181 | 0.4300HKD | -1.15% | 9.46K $ |
Quotes 5-day view: Mabpharm Limited
Delayed Quote Hong Kong S.E.
| 2026-10-27 | 2026-10-28 | 2026-10-29 | 2026-10-30 | Today | |
|---|---|---|---|---|---|
| Last | HK$0.4350 | HK$0.4350 | HK$0.4350 | HK$0.4350 | HK$0.4300 |
| Volume | 102,000 | 0 | 72,000 | 0 | 22,000 |
| Change | -1.14% | 0.00% | 0.00% | 0.00% | -1.15% |
| Opening | HK$0.4250 | HK$0.4350 | HK$0.4300 | HK$0.4350 | HK$0.4250 |
| High | HK$0.4350 | HK$0.4350 | HK$0.4350 | HK$0.4350 | HK$0.4350 |
| Low | HK$0.4250 | HK$0.4350 | HK$0.4250 | HK$0.4350 | HK$0.4250 |
Performance
| 1 day | -1.15% | ||
| 1 week | -6.52% | ||
| Current month | -1.15% | ||
| 1 month | -4.44% | ||
| 3 months | +7.50% | ||
| 6 months | -3.37% | ||
| Current year | -14.00% | ||
| 1 year | -17.31% | ||
| 3 years | -8.51% | ||
| 5 years | -63.25% |
Volumes
marketsDaily volume
22,000
Estimated daily volume
22,000
Avg. Volume 20 sessions
23,143
Daily volume ratio
0.95
Avg. Volume 20 sessions HKD
9,951.49
Avg. Volume 20 sessions USD
1,268.32
Record volume 1
167,506,000
Record volume 2
91,768,000
Record volume 3
56,694,500
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (HKD)
1,520,826,516
Market Cap (USD)
228,671,646
Net sales ()
646,095,000
Net sales (USD)
97,146,917
Number of employees
394
Sales / Employee (CNY)
1,639,835
Sales / Employee (USD)
246,566
Free-Float
22.82%
Free-Float capitalization (HKD)
347,106,113
Free-Float capitalization (USD)
52,190,914
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
0.436
Moving average 20 days
0.4793
Moving average 50 days
0.4539
Moving average 100 days
0.4304
Price spread / (MMA5)
+1.40%
Price spread / (MMA20)
+11.47%
Price spread / (MMA50)
+5.56%
Price spread / (MMA100)
+0.09%
STIM
RSI 9 days
33.62
RSI 14 days
40.89
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.15% | -6.52% | -17.31% | -8.51% | 229M | |
| -2.37% | -4.19% | +39.49% | +63.21% | 63.77B | |
| -2.87% | +0.49% | +10.45% | +69.18% | 56.37B | |
| +0.62% | +2.11% | +20.22% | +102.56% | 54.62B | |
| -2.32% | -4.91% | +21.64% | +36.59% | 44.06B | |
| -1.92% | -2.01% | +16.54% | +99.63% | 42.11B | |
| -0.24% | +3.91% | +222.09% | +803.52% | 41B | |
| -5.47% | +24.76% | +98.34% | +87.34% | 34.92B | |
| +0.21% | -1.23% | +14.81% | +47.35% | 32.82B | |
| -1.16% | +19.01% | -40.36% | +344.12% | 24.7B | |
| Average | -1.66% | +6.41% | +38.59% | +164.50% | 39.46B | |
| Weighted average by Cap. | -1.72% | +5.63% | +45.33% | +165.72% |
Historical Quotes: Mabpharm Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
8e493c2824a6762eeeed51703b9679.vX2gPU7Jn9oh6XGr65tO8ZQyNXegaJro18fVk1kr968.9BWUbWO63O1ukDXome8_xNFeRzLDPPKioK2mw2tjhMfcB9hRDPDwv3maFg
| Date | Price | Volume | Total |
|---|---|---|---|
| 02:06:17 | 0.4300 | 2,000 | 22,000 |
| 20:41:20 | 0.4350 | 18,000 | 20,000 |
Price Extremes
| 1 week | 0.42 |  | 0.44 |
| 1 month | 0.42 | | 0.55 |
| Current year | 0.31 | | 0.81 |
| 1 year | 0.31 | | 0.81 |
| 3 years | 0.25 | | 0.94 |
| 5 years | 0.25 | | 1.2 |
| 10 years | 0.25 | | 1.8 |
Monthly variations
Annual variations
| 2026 | -14.00% | ||
| 2025 | +78.57% | ||
| 2024 | -39.13% | ||
| 2023 | +5.75% | ||
| 2022 | -56.50% | ||
| 2021 | -4.76% | ||
| 2020 | -8.70% | ||
| 2019 | -4.96% |
- Stock Market
- Stocks
- 2181 Stock
- Quotes Mabpharm Limited
Select your edition
All financial news and data tailored to specific country editions
